Marine Derived Drugs Market: Trends and industry Analysis – 2018

Over 50% of the world’s most popular drugs are sourced directly or indirectly from natural sources. Pioneering research in marine based drug discovery began with Roche Research Institute of Marine Pharmacology during the mid 1970s. Tethya crypta a marine sponge was the first organism to be commercialized to produce drugs against HIV & Herpes. A small number of marine organisms primarily constituting of algae and other invertebrates have already been researched for commercial value in pharmaceuticals.

Download exclusive Sample of this report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=895

Marine organisms have been found to be capable of providing solutions for major human diseases such as cancer, Alzheimer’s, herpes and many others. With the rate of success and growth in this area, it is expected that the market for marine-derived pharmaceutical products will increase in the coming months rapidly and double by 2018. Several of the marine organisms used for extracting drugs are deep sea bacteria, sponges, mollusks, fungi, and tunicates. Even with such strong R&D activities in marine organisms, it is believed that no more than 10% of organisms have been researched as potential candidates.

A large number of marine organisms still remain viable avenues for research.
Primary research and market analysis shows sponges and marine animals to be the largest source of pharmaceutical products. In terms of geography, North America is expected to be the largest market for marine based pharmaceuticals. The history of marine-derived products began from cod-liver oil, shark oil, and calcium supplements. Marine biotechnology has developed over the years propelled by the unmet needs for new and innovative pharmaceutical products. Potential pipeline drugs being developed are anti-viral, anti-cancer drugs from byrozoans, anti-microbial, and anti-inflammatory.

View exclusive Global strategic Business report :
http://www.transparencymarketresearch.com/global-market-for-marine-derived-drugs.html

Increasing marine biodiversity preservation and research programs throughout the world are a definite sign that the world is getting ready for a new variety of pharmaceutical compounds that would be fighting a broad spectrum of diseases. With an estimated 70% organisms to be investigated, pharmaceutical companies hope to find a cure for high-risk and fatal diseases in the coming years. Marine organisms are expected to be viable for production of drug compounds, biomaterials, nutritional supplements, and several types of algae are being used for the production of alcohol as an energy source.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
North America
Asia Pacific
Europe
Rest of the World

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.